Reevaluating Treatment for ESUS

This chapter examines the treatment strategies for embolic stroke of undetermined source (ESUS) by comparing the effectiveness of antiplatelet agents and anticoagulants. It highlights a study indicating no significant benefits of anticoagulation over antiplatelet therapy, urging a reconsideration of traditional approaches and the importance of recognizing patient-specific risk factors.